Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume -, Issue -, Pages 1-6
Publisher
Informa UK Limited
Online
2019-08-02
DOI
10.1080/0284186x.2019.1643036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer
- (2019) Ali Ayhan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer
- (2018) Ellen Cusano et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer
- (2018) Marie Sato et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Swedish cause of death register
- (2017) Hannah Louise Brooke et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group
- (2017) K. Stålberg et al. INTERNATIONAL JOURNAL OF CANCER
- Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer
- (2016) Soledad Jorge et al. GYNECOLOGIC ONCOLOGY
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
- (2016) Nicoletta Colombo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring System
- (2015) Sofiane Bendifallah et al. ANNALS OF SURGICAL ONCOLOGY
- Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer
- (2015) Ulas Solmaz et al. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
- Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
- (2015) Tjalling Bosse et al. EUROPEAN JOURNAL OF CANCER
- Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer
- (2015) Koji Matsuo et al. JOURNAL OF SURGICAL ONCOLOGY
- A Risk Scoring System to Determine Recurrence in Early-Stage Type 1 Endometrial Cancer: A French Multicentre Study
- (2014) Sofiane Bendifallah et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: A SEER analysis
- (2014) Roberto Vargas et al. GYNECOLOGIC ONCOLOGY
- Lymphovascular Space Invasion (LVSI) Is an Isolated Poor Prognostic Factor for Recurrence and Survival Among Women With Intermediate- to High-Risk Early-Stage Endometrioid Endometrial Cancer
- (2013) Lori E. Weinberg et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer
- (2011) Saketh R. Guntupalli et al. GYNECOLOGIC ONCOLOGY
- Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality
- (2009) DJ O’Brien et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- The completeness of the Swedish Cancer Register – a sample survey for year 1998
- (2008) Lotti Barlow et al. ACTA ONCOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started